Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer.
Saved in:
| Title: | Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer. |
|---|---|
| Authors: | Wang, Junbiao1 (AUTHOR), Lamolinara, Alessia2 (AUTHOR), Tomassoni, Daniele1,3 (AUTHOR), Conti, Laura3,4 (AUTHOR), Cossu, Chiara3,5 (AUTHOR), Di Lorenzo, Antonino3,6 (AUTHOR), Giangrossi, Mara1,7 (AUTHOR), Lufrano, Daniela1,4,8 (AUTHOR), Vaithianathan, Varshini1 (AUTHOR), Orlando, Fiorenza2,5 (AUTHOR), Olivieri, Fabiola3,6,7 (AUTHOR), Marcozzi, Serena4,7 (AUTHOR), Beghelli, Daniela1,5 (AUTHOR), Belletti, Barbara6,8 (AUTHOR), Amici, Augusto1,7 (AUTHOR), Falconi, Maurizio1,8 (AUTHOR) s.marcozzi@inrca.it, Cavallo, Federica3 (AUTHOR), Iezzi, Manuela2 (AUTHOR), Marchini, Cristina1 (AUTHOR) cristina.marchini@unicam.it |
| Source: | Pharmaceutics. Jul2026, Vol. 18 Issue 7, p881. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics18070881 |
